Total Cancer Care: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer

A
Anna Maria Storniolo, MD

Primary Investigator

Recruiting
18 years - 100 years
All
Phase N/A
2 Locations

Brief description of study

What is the purpose of this study?
The purpose of this research study is to collect and store biospecimens and personal health information to use in future research studies. The Total Cancer Care Program (TCCP) establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This research study is to build a large database (of information and specimens) to find better ways to prevent, diagnose and treat cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.


Detailed description of study

What will happen during the study?
  • After enrollment, subjects may have archived tissue collected (research or clinical), fresh tissue collected at the time of planned surgery or biopsy, blood collected (up to 2 tablespoon four times per year with optional consent to 5 tablespoons during two of these draws. The amount of blood to be drawn for pediatric patients will not exceed the lesser of 50 ml or 3 ml/kg in an 8-week period and blood will not be drawn more than two times per week). All samples will be collected during standard of care appointments. Clinical information collected through review of electronic medical records, will be reviewed periodically and participants may be contacted to provide additional information on an annual basis if they agree to being recontacted.
  • Surviving next of kin or legal representative may complete enrollment, and then archived tissue will be requested.
  • Consent currently outlines possibility of having additional biospecimens collected (e.g. saliva). We have rolled out the collection of urine, buccal cells, blood, tissue, bone marrow, and peritoneal/pleural fluids at this time.
  • Patients and their existing biospecimens and data from any protocol noted in the "Release Protocol" in the Notes & Attachments tab may be rolled into Total Cancer Care Protocol (IUSCC-0678) under a waiver of consent/authorization, consistent with the "Release Protocol".
  • Tissue from special patient groups (pregnant women, mentally disabled, prisoners, economically or educationally disadvantaged) might be collected, but these groups would not be specifically sought out.
Additional Information:  Participants will not be paid for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cancer
  • Age: 18 years - 100 years
  • Gender: All

Inclusion Criteria
  •     18 years of age and older.
  •     Has a diagnosis of cancer or is suspected of having cancer.
  •     Able to understand and sign the Informed Consent form directly.
  •     Pregnant women are permitted to be enrolled.

Updated on 01 Aug 2024. Study ID: 1807389306, IUSCC-0678

Find a site

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center